Benjamin Russell Clouse net worth and biography

Benjamin Clouse Biography and Net Worth

Sr. VP & CFO of Waddell & Reed Financial

Ben Clouse is Chief Financial Officer of CrossFirst Bankshares, Inc., leading the financial organization and overall long-range financial planning and reporting as well as supporting the execution of the bank’s growth strategy.

Prior to joining CrossFirst, Mr. Clouse was CFO of Waddell & Reed, Financial, Inc. (Waddell). Waddell was the holding company for one of the oldest mutual fund companies in the United States (Ivy Funds) and a nationwide broker-dealer and investment advisor (Waddell & Reed Financial Advisors).

Mr. Clouse began his career in the audit practice of Deloitte and has held successive roles of increasing responsibility across multiple financial disciplines in a variety of industries including financial services, banking, consumer retail and digital, and transportation. Mr. Clouse obtained a business degree and a Master of Accountancy degree from Kansas State University and has been previously licensed as a Certified Public Accountant and previously designated as a Financial Industry Regulatory Authority (FINRA) Series 27 Financial and Operations Principal license holder.

How old is Benjamin Russell Clouse?: Mr. Clouse is currently 48 years old. There are 6 older executives and no younger executives at Waddell & Reed Financial. The oldest executive at Waddell & Reed Financial is Mr. Philip James Sanders C.F.A., CFA, MBA, CEO & Director, who is 62 years old. Learn More on Benjamin Russell Clouse's age.
How do I contact Benjamin Russell Clouse?: The corporate mailing address for Mr. Clouse and other Waddell & Reed Financial executives is 6300 LAMAR AVE, OVERLAND PARK KS, 66201. Waddell & Reed Financial can also be reached via phone at 913-236-2000 and via email at [email protected]. Learn More on Benjamin Russell Clouse's contact information.
Has Benjamin Russell Clouse been buying or selling shares of Waddell & Reed Financial?: Benjamin Russell Clouse has not been actively trading shares of Waddell & Reed Financial during the last quarter. Learn More on Benjamin Russell Clouse's trading history.
Who are Waddell & Reed Financial's active insiders?: Waddell & Reed Financial's insider roster includes Benjamin Clouse (Sr. VP & CFO ), and Philip Sanders (CFA). Learn More on Waddell & Reed Financial's active insiders.

Benjamin Russell Clouse Insider Trading History at Waddell & Reed Financial

Benjamin Russell Clouse Buying and Selling Activity at Waddell & Reed Financial

Waddell & Reed Financial Company Overview

Waddell & Reed Financial, Inc., through its subsidiaries, provides investment management and advisory, investment product underwriting and distribution, and shareholder services administration to mutual funds, and institutional and separately managed accounts in the United States. The company acts as an investment adviser for institutional and other private investors, and provides sub advisory services to other investment companies; and underwrites and distributes registered open-end mutual fund portfolios. It also offers fee-based asset allocation investment advisory products to advisors channel customers; distributes business partners' variable annuity products, and retirement and life insurance products to advisors channel customers; and sells life insurance and disability products underwritten by various carriers. The company distributes investment products through its wholesale channel comprising other broker/dealers, various retirement platforms, and registered investment advisors, as well as through independent financial advisors; and markets investment advisory services to institutional investors directly or through consultants. Waddell & Reed Financial, Inc. was founded in 1937 and is based in Overland Park, Kansas.

Today's Range

Now: $24.98

$24.98

$25.00

50 Day Range

MA: $24.97

$24.93

$25.00

2 Week Range

Now: $24.98

$12.46

$25.90

Volume

5,534,095 shs

Average Volume

750,422 shs

Market Capitalization

$1.55 billion

P/E Ratio

17.97

Dividend Yield

4.00%

Beta

1.44

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>